A large seven-country study has shed light on how serious people find the COVID-19 pandemic compared to other major public health problems. The results were surprising and provide guidance to healthcare providers as well as policymakers.
Researchers from seven EfD centers plus the EfD Global Hub have conducted an extensive survey, led by Professors Richard Carson, Dale Whittington, and Michael Hanemann. This study is now bearing fruit in the form of publications, the first being: Perceptions of the seriousness of major public health problems during the COVID-19 pandemic in seven middle-income countries.
Respiratory illnesses ranked more serious
The researchers designed a survey, and hired YouGov, a survey research firm, to administer it in seven countries in Africa, Asia, and Latin America to over 10,000 respondents in early 2022. The respondents answered the questions on their computers, tablets, or smartphones. They ranked the seriousness of the seven health problems (alcoholism and drug use, HIV/AIDS, malaria, tuberculosis, lung cancer and respiratory diseases caused by air pollution and smoking, and water-borne diseases like diarrhea) using a repeated best-worst question format.
Their answers revealed that in most countries respiratory illnesses were perceived to be a more serious problem than COVID-19. Surprisingly, in six of the seven countries, respondents ranked waterborne diseases as the least serious health problem. In the seventh country (South Africa) it was ranked next to last. In Africa, people felt that alcoholism and drug use were also more serious than COVID-19.
Don’t crowd out ordinary healthcare
These findings are important because they show that people still care about the health problems they were facing before the pandemic.
“An important lesson for health ministries is to not get too carried away by what media focuses on a particular point in time. It is important to avoid crowding out ordinary health services,” says Dale Whittington.
“It’s also clear that public perceptions of the seriousness of health problems can differ considerably within and across countries and population segments defined by demographics and knowledge.”
EfD Director Gunnar Köhlin notes that the study is unique in the way it has tied together researchers from seven countries in the Global South with leading researchers in the US and Sweden in a joint data collection and analysis effort.
“A study like this can put novel phenomena, such as the COVID-19 pandemic, into a perspective of the more persistent challenges that countries in the Global South face,” he says.